SEC Form 4
Cognition Therapeutics, Inc. (CGTX) insider trading
In the 12 months to Oct 26, 2026, 3 CGTX insiders reported open-market purchases of $32.5K across 3 filings; no open-market sales were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $0
- 0 filings · 0 insiders
- Open-market purchases
- $32.5K
- 3 filings
Who traded CGTX, and when
- Purchase
CGTX daily close from Oct 27, 2025 to Oct 26, 2026, between $0.59 and $1.80, last $0.71. 0 sale and 3 purchase filings by 3 insiders, marked at their filing dates. John Brendan Doyle, Chief Financial Officer: bought $11.3K across 1 filing, first filed Apr 20, 2026, last Apr 20, 2026. Anthony Caggiano, Chief Medical Officer: bought $11.1K across 1 filing, first filed Apr 20, 2026, last Apr 20, 2026. Lisa Ricciardi, CEO & President: bought $10.1K across 1 filing, first filed Apr 20, 2026, last Apr 20, 2026.
Largest mark · tap a row for others
John Brendan Doyle · Chief Financial Officer
Purchase $11,300
10,000 shares at $1.13 avg
Filed Apr 20, 2026 · traded Apr 16
Close on filing date $1.12
John Brendan Doyle · Chief Financial Officer
Chief Financial Officer
$11.3K boughtAnthony Caggiano · Chief Medical Officer
Chief Medical Officer
$11.1K boughtLisa Ricciardi · CEO & President
CEO & President
$10.1K boughtOpen-market trades
3 filings in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| John Brendan Doyle | Chief Financial Officer | — | $11.3K | 1 | — | |
| Anthony Caggiano | Chief Medical Officer | — | $11.1K | 1 | — | |
| Lisa Ricciardi | CEO & President | — | $10.1K | 1 | — |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Anthony Caggiano Chief Medical Officer | Purchase | 10,000 | $1.11 | $11.1K | 874,906 | |
traded | Lisa Ricciardi CEO & President | Purchase | 9,175 | $1.10 | $10.1K | 1,715,851 | |
traded | John Brendan Doyle Chief Financial Officer | Purchase | 10,000 | $1.13 | $11.3K | 627,509 |
GET /stocks/filings/vX/form-4?tickers=CGTX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"CGTX"
],
"issuer_cik": "0001455365",
"owner_cik": "0001418200",
"accession_number": "0001104659-26-045502",
"form_type": "4",
"filing_date": "2026-04-20",
"period_of_report": "2026-04-16",
"issuer_name": "COGNITION THERAPEUTICS INC",
"issuer_trading_symbol": "CGTX",
"owner_name": "Ricciardi Lisa",
"is_director": true,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "CEO & President",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-04-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 9175,
"transaction_price_per_share": 1.1,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 1715851,
"transaction_value": 10092.5,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
},
{
"tickers": [
"CGTX"
],
"issuer_cik": "0001455365",
"owner_cik": "0001840738",
"accession_number": "0001104659-26-045511",
"form_type": "4",
"filing_date": "2026-04-20",
"period_of_report": "2026-04-16",
"issuer_name": "COGNITION THERAPEUTICS INC",
"issuer_trading_symbol": "CGTX",
"owner_name": "Doyle John Brendan",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Chief Financial Officer",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": false,
"transaction_date": "2026-04-16",
"transaction_code": "P",
"equity_swap_involved": false,
"transaction_shares": 10000,
"transaction_price_per_share": 1.13,
"transaction_acquired_disposed": "A",
"shares_owned_following_transaction": 627509,
"transaction_value": 11299.999999999998,
"not_subject_to_section_16": false,
"direct_or_indirect": "D"
}
]
}
// trimmed to 2 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 23 records
- Tax withholding12 records
- Grants and awards11 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has Cognition Therapeutics, Inc.'s CEO sold stock?
No. Lisa Ricciardi (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is CGTX’s insider data?
These are CGTX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track CGTX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for CGTX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.